Friederike L Keggenhoff
Overview
Explore the profile of Friederike L Keggenhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keggenhoff F, Castven D, Becker D, Stojkovic S, Castven J, Zimpel C, et al.
Gut
. 2024 Jun;
73(10):1712-1724.
PMID: 38857989
Objective: Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer with limited therapeutic options. mutations are among the most abundant genetic alterations in iCCA associated with poor clinical...
2.
Lewinska M, Zhuravleva E, Satriano L, Martinez M, Bhatt D, Oliveira D, et al.
Gastroenterology
. 2023 Dec;
166(5):886-901.e7.
PMID: 38096955
Background & Aims: Metabolic and transcriptional programs respond to extracellular matrix-derived cues in complex environments, such as the tumor microenvironment. Here, we demonstrate how lysyl oxidase (LOX), a known factor...
3.
Ma L, Heinrich S, Wang L, Keggenhoff F, Khatib S, Forgues M, et al.
Nat Commun
. 2022 Dec;
13(1):7533.
PMID: 36476645
Intratumor heterogeneity may result from the evolution of tumor cells and their continuous interactions with the tumor microenvironment which collectively drives tumorigenesis. However, an appearance of cellular and molecular heterogeneity...
4.
Gerardo-Ramirez M, Keggenhoff F, Giam V, Becker D, Groth M, Hartmann N, et al.
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955749
Osteosarcoma is the most common type of pediatric bone tumor. Despite great advances in chemotherapy during the past decades, the survival rates of osteosarcoma patients remain unsatisfactory. Drug resistance is...